Moloney Securities Asset Management LLC Has $533,000 Stock Holdings in Fabrinet (NYSE:FN)

Moloney Securities Asset Management LLC lifted its holdings in Fabrinet (NYSE:FN) by 47.4% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,423 shares of the technology company’s stock after buying an additional 779 shares during the quarter. Moloney Securities Asset Management LLC’s holdings in Fabrinet were worth $533,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in FN. Barclays PLC raised its stake in shares of Fabrinet by 304.6% in the third quarter. Barclays PLC now owns 69,128 shares of the technology company’s stock worth $16,345,000 after acquiring an additional 52,042 shares during the last quarter. nVerses Capital LLC acquired a new position in Fabrinet during the 3rd quarter worth $567,000. Charles Schwab Investment Management Inc. lifted its holdings in Fabrinet by 14.7% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 480,550 shares of the technology company’s stock worth $113,621,000 after buying an additional 61,491 shares in the last quarter. Dynamic Technology Lab Private Ltd bought a new position in Fabrinet in the 3rd quarter valued at $2,398,000. Finally, Pathstone Holdings LLC raised its position in shares of Fabrinet by 40.7% during the third quarter. Pathstone Holdings LLC now owns 8,219 shares of the technology company’s stock worth $1,943,000 after acquiring an additional 2,378 shares during the last quarter. Institutional investors and hedge funds own 97.38% of the company’s stock.

Fabrinet Stock Performance

FN opened at $210.99 on Tuesday. The firm’s fifty day moving average is $229.66 and its two-hundred day moving average is $233.72. The firm has a market cap of $7.65 billion, a PE ratio of 23.60 and a beta of 0.92. Fabrinet has a twelve month low of $159.69 and a twelve month high of $281.79.

Fabrinet (NYSE:FN) last issued its quarterly earnings data on Monday, February 3rd. The technology company reported $2.38 EPS for the quarter, missing the consensus estimate of $2.48 by ($0.10). Fabrinet had a return on equity of 18.48% and a net margin of 10.44%. Equities analysts forecast that Fabrinet will post 9.4 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on FN shares. B. Riley lowered Fabrinet from a “neutral” rating to a “sell” rating and cut their price target for the company from $194.00 to $178.00 in a research note on Wednesday, November 20th. Needham & Company LLC reiterated a “buy” rating and set a $280.00 price target on shares of Fabrinet in a research report on Tuesday, February 4th. Rosenblatt Securities lifted their price target on shares of Fabrinet from $280.00 to $285.00 and gave the stock a “buy” rating in a research report on Tuesday, February 4th. Barclays cut their price objective on shares of Fabrinet from $292.00 to $245.00 and set an “equal weight” rating on the stock in a report on Tuesday, February 4th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Fabrinet from $275.00 to $265.00 and set a “neutral” rating for the company in a research report on Tuesday, February 4th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and three have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $243.29.

Fabrinet Company Profile

Fabrinet provides optical packaging and precision optical, electro-mechanical, and electronic manufacturing services in North America, the Asia-Pacific, and Europe. The company offers a range of advanced optical and electro-mechanical capabilities in the manufacturing process, including process design and engineering, supply chain management, manufacturing, printed circuit board assembly, advanced packaging, integration, final assembly, and testing.